Literature DB >> 6250807

Experimental models for study of common respiratory viruses.

W A Clyde.   

Abstract

Numerous epidemiological studies have shown that there is excess respiratory disease morbidity in areas of high atmospheric pollution, implying an interactive effect on the clinical illness associated with these common infections. The principal etiologic agents of human respiratory infections are respiratory syncytial virus (RSV), influenza viruses (IV), parainfluenza virus types 1 and 3 (P1, P3), adenoviruses (AD), rhinoviruses (RV) and Mycoplasma pneumoniae (Mpn). Understanding the pathogenesis of the excess morbidity related to pollutants would facilitate detection of undesirable human health effects and provide a basis for intervention strategies. Through use of experimental model systems the mechanism of toxic effects could be defined (whether microbiological, immunological, pathological or physiological) to provide direction for appropriate studies in the human host. Small animal models of IV and Mpn infections have been available for many years; recently, experimental models of several more common viral diseases have been developed. A parallel to human RSV infections is provided by the ferret: virus replicates in the lungs of infant animals, but only in the noses of adults. The common cotton rat infected with RSV develops small airways lesions which may mimic the pathophysiologic changes of bronchiolitis. Both guinea pigs and Syrian hamsters are susceptible to human P3 virus, developing peribronchiolar and interstitial lesions. Practical small animal models for human AD and RV infections are not available because of the high host-specificity of these agents. Both the RSV and P3 model infections are nonlethal which enables study for long-term sequelae. Recent reports of pulmonary function abnormalities among children suffering bronchiolitis in infancy underscores the importance of defining toxic influences which could play a role by making the initial infections more severe.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250807      PMCID: PMC1568449          DOI: 10.1289/ehp.8035107

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  13 in total

1.  PARAINFLUENZA TYPE 3 VIRUS INFECTION IN HAMSTERS: VIROLOGIC, SEROLOGIC, AND PATHOLOGIC STUDIES.

Authors:  D A BUTHALA; M G SORET
Journal:  J Infect Dis       Date:  1964-06       Impact factor: 5.226

2.  Inoculation of pigs with adenoviruses of man.

Authors:  A O BETTS; A R JENNINGS; P H LAMONT; Z PAGE
Journal:  Nature       Date:  1962-01-06       Impact factor: 49.962

3.  Experimentally induced respiratory syncytial viral infection in calves.

Authors:  S B Mohanty; A L Ingling; M G Lillie
Journal:  Am J Vet Res       Date:  1975-04       Impact factor: 1.156

Review 4.  Model systems for studying the pathogenesis of infections causing bronchiolitis in man.

Authors:  A M Collier; W A Clyde
Journal:  Pediatr Res       Date:  1977-03       Impact factor: 3.756

5.  Experimental respiratory syncytial virus infection of four species of primates.

Authors:  R B Belshe; L S Richardson; W T London; D L Sly; J H Lorfeld; E Camargo; D A Prevar; R M Chanock
Journal:  J Med Virol       Date:  1977       Impact factor: 2.327

6.  Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice.

Authors:  W P Glezen; F A Loda; W A Clyde; R J Senior; C I Sheaffer; W G Conley; F W Denny
Journal:  J Pediatr       Date:  1971-03       Impact factor: 4.406

7.  [Experimental RS virus infection of cotton rats. A viral and immunofluorescent study].

Authors:  R S Dreĭzin; L O Vyshnevetskaia; E E Bagdamian; O D Iankevich; L B Tarasova
Journal:  Vopr Virusol       Date:  1971 Nov-Dec

8.  The pathogenesis of respiratory syncytial virus infection in infant ferrets.

Authors:  G A Prince; D D Porter
Journal:  Am J Pathol       Date:  1976-02       Impact factor: 4.307

9.  Injury of respiratory epithelium.

Authors:  A M Collier
Journal:  Environ Health Perspect       Date:  1980-04       Impact factor: 9.031

10.  Experimental infection of the respiratory tract with Mycoplasma pneumoniae.

Authors:  P C Hu; J M Kirtz; D E Gardner; D A Powell
Journal:  Environ Health Perspect       Date:  1980-04       Impact factor: 9.031

View more
  7 in total

1.  Viral detection using DNA functionalized gold filaments.

Authors:  Jonas W Perez; Frederick R Haselton; David W Wright
Journal:  Analyst       Date:  2009-05-15       Impact factor: 4.616

2.  Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.

Authors:  Anna R Kwilas; Mark A Yednak; Liqun Zhang; Rachael Liesman; Peter L Collins; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 3.  Current issues and future directions of oncolytic adenoviruses.

Authors:  Masato Yamamoto; David T Curiel
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

Review 4.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

Review 5.  The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer

Authors:  Mizuho Sato-Dahlman; Masato Yamamoto
Journal:  Curr Cancer Drug Targets       Date:  2018       Impact factor: 3.428

6.  Hamster tracheal organ culture in serum-free media: a quantitative comparison of in vitro epithelial morphology with that of in vivo controls.

Authors:  R E Sigler; R T Jones; J R Hebel; E M McDowell
Journal:  In Vitro Cell Dev Biol       Date:  1987-02

Review 7.  Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention.

Authors:  Jessie R Groothuis; J Michael Hoopes; Val G Hemming Jessie
Journal:  Adv Ther       Date:  2011-02-04       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.